Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes.
about
Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based studyAntimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort StudySkin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based studyPrevalence and factors associated with wound colonization by Staphylococcus spp. and Staphylococcus aureus in hospitalized patients in inland northeastern Brazil: a cross-sectional study.In vivo activity of anprocide alone, and in vitro activity in combination with conventional antibiotics against Staphylococcus aureus and Staphylococcus epidermidis biofilms.Neuroendocrine nicotinic receptor activation increases susceptibility to bacterial infections by suppressing antimicrobial peptide productionFactors associated with variation in estimates of the cost of resistant infectionsAntibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: a multi-country medical chart review in EuropeDevelopment and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections.A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes.Bone and joint infections due to anaerobic bacteria: an analysis of 61 cases and review of the literature.A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infectionsEpidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patientsDirect molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infectionsClinical features and outcome of bone and joint infections with streptococcal involvement: 5-year experience of interregional reference centres in the south of France.Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients.Estradiol ameliorates arthritis and protects against systemic bone loss in Staphylococcus aureus infection in mice.Examination of hospital length of stay in Canada among patients with acute bacterial skin and skin structure infection caused by methicillin-resistant Staphylococcus aureus.Cost comparison of linezolid versus vancomycin for treatment of complicated skin and skin-structure infection caused by methicillin-resistant Staphylococcus aureus in QuebecMoxifloxacin in complicated skin and skin structure infections (cSSSIs): A prospective, international, non-interventional, observational study.The evaluation and treatment of complicated skin and skin structure infections.Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.Quality assessment of hospital discharge database for routine surveillance of hip and knee arthroplasty-related infections.Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation.Early-switch/early-discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections: proof of concept in the United Arab Emirates.Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.In vitro Antimicrobial Activity of Chlorquinaldol against Microorganisms Responsible for Skin and Soft Tissue Infections: Comparative Evaluation with Gentamicin and Fusidic Acid.False economies in home-based parenteral antibiotic treatment: a health-economic case study of management of lower-limb cellulitis in Australia.Orthopaedic biofilm infections.Causality evaluation of bacterial species isolated from patients with community-acquired lower leg cellulitis.Surgical site infection after primary hip and knee arthroplasty: a cohort study using a hospital database.Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline.Antibiotic prescribing practices in a multicenter cohort of patients hospitalized for acute bacterial skin and skin structure infection.Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease.TLR1, TLR2, and TLR6 gene polymorphisms are associated with increased susceptibility to complicated skin and skin structure infections.Paediatric bone and joint infections are more common in boys and toddlers: a national epidemiology study.Characterization of the interaction between liposomal formulations and Pseudomonas aeruginosa.
P2860
Q28384260-096C3306-519D-4C62-8712-16F1B8348ED1Q28393128-EAC333DB-1F50-4733-808E-92F9C202E3A3Q28603779-0DA8E9A9-4630-4912-BCB9-0B599580708FQ33595221-B528B9A7-476A-4626-BDA5-24374A7D3FA8Q33784232-DBD4254E-8426-493A-9A5F-2F1155DBF755Q33920470-F6B2414B-433A-48EF-A60B-F927B04E6E19Q34044895-0F1071DA-4A32-4AA1-9C85-89107A7BD9B7Q34077002-021BD327-835E-478E-A8A5-9240D17BF8D7Q34133346-E0A23155-49A4-42CF-8C93-9C14FF43AC84Q34185105-E38D201D-808E-40E2-9207-04E4CF8F3E70Q34333299-D7FD3CC7-C8D6-465C-B2E5-ADC61D93E864Q34420942-366A18D6-8AFB-4E79-9479-4C4B1D9179D7Q35104274-97F624B6-0F0B-4DCD-B020-E1C470EED202Q35328383-81A79FC7-2B0E-4BF1-8991-051991A40990Q35688982-336B10EF-4D58-48D0-8288-2561608666D2Q35983355-AB153955-9166-4518-933B-10C445DF2B91Q36028844-CB279712-3B51-4CDE-80EB-1220F17AD501Q36207015-660AA7D5-8FE3-429C-BA78-5E2133D6D30FQ36245810-A9849F8D-E2CF-46B5-8F9A-DCFF3CDCE3AFQ36525836-5EE89657-3E32-4D76-9446-0D523400BB45Q36684268-4262B70E-37C0-44CD-8FB8-8BB91E9FFD05Q36997690-0BA13380-0A52-43CB-8377-8D8B721A1811Q37111836-BFA72323-0AB5-4117-9D92-A129A1CF0DC5Q37593094-2571B63E-D777-47F6-B2CB-EAE1F2B37A90Q38185097-88DFB3C9-B39F-47AB-8967-4417D8C62707Q38209647-7A63DD6E-1DDF-4136-A950-018C4EB2FE3AQ38411792-8E310B2E-668B-43A0-883D-D573FC608BFCQ38540488-154AD19F-2C3F-4E13-82B3-9C8E598E483EQ38575717-A89E8AD0-D501-4FD3-9643-FF800804C17EQ40161237-326098F2-CE46-4DCB-B119-58316FF8134EQ40172547-1ED571A9-93F9-493F-AFC2-D07733AF5784Q40252041-7999D677-626D-49DB-BA49-3C7EF3E30C81Q40618244-5040CE8C-4DF0-4EDC-A193-F64908A0075EQ41118277-F55B5775-B97D-489C-824A-A0D6215BFE80Q41123210-C72C1239-C1CD-4D7D-AA0B-DA4E1B726B15Q41731700-9D914C2A-4F2F-4A85-8D1E-6302216BB0EFQ41858729-2CA5C265-A4C9-44B1-A26E-962825E4101FQ42229180-3CEF60C5-F127-4199-84E1-8BBF0981B49BQ42284126-DCEC8B34-AA5D-4EBB-A57C-4861C9DE014EQ44855920-58654B10-1721-4708-AF9F-2C9EEC2B8924
P2860
Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Skin, soft tissue, bone, and j ...... inical, and economic outcomes.
@en
Skin, soft tissue, bone, and j ...... inical, and economic outcomes.
@nl
type
label
Skin, soft tissue, bone, and j ...... inical, and economic outcomes.
@en
Skin, soft tissue, bone, and j ...... inical, and economic outcomes.
@nl
prefLabel
Skin, soft tissue, bone, and j ...... inical, and economic outcomes.
@en
Skin, soft tissue, bone, and j ...... inical, and economic outcomes.
@nl
P2093
P2860
P356
P1476
Skin, soft tissue, bone, and j ...... inical, and economic outcomes.
@en
P2093
Aaron Killian
John A Weigelt
Michael M Peng
Vikas Gupta
P2860
P304
P356
10.1086/520743
P577
2007-10-03T00:00:00Z